These data suggest that Ad-VT plays a role in chemotherapy resistance at the molecular level by affecting the protein expression of constituents of the PI3K/Akt/mTOR signaling pathway, which can be exploited to improve the sensitivity of drug-resistant lung cancer cell lines to chemotherapy. This evidence concerns the gene AKT1 and lung cancer.